Keyphrases
17α-Hydroxylase
19%
Activin
69%
Androgens
20%
Atosiban
19%
Binding Protein
20%
Breast Cancer
27%
Breech
19%
Cancer Incidence
21%
COVID-19 Impact
19%
Endogenous Catecholamines
29%
Estrogen
20%
Fertilization Failure
19%
Fetal Heart Rate
19%
Fibroids
30%
Focused Ultrasound Surgery
47%
Follicle-stimulating Hormone
51%
Follicular Fluid
27%
Gonadotropin-releasing Hormone
56%
Granulosa Cells
52%
Growth Factor Binding
19%
Growth Factors
36%
Human Ovary
22%
In Vitro Fertilization
56%
In Vitro Fertilization Cycle
23%
Infertile Women
27%
Infertility
49%
Inhibin
29%
Insulin-like
41%
Leukocytes
19%
Luteinization
23%
Luteinizing Hormone
34%
Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
55%
Magnetic Resonance-guided Focused Ultrasound Surgery
58%
MRNA Vaccine
19%
Ovarian Follicle
23%
Ovarian Hyperstimulation Syndrome
36%
Ovulation Induction
27%
Pituitary
20%
Polycystic Ovary Syndrome
29%
Pre-ovulatory
20%
Progestogens
19%
Prospective Randomized Trial
22%
Standardized Incidence Ratio
25%
Steroid Secretion
19%
Symptomatic Uterine Fibroids
27%
Tocolysis
19%
Total Failure
19%
Ultrasound Treatment
32%
Uterine Fibroids
60%
Uterine Leiomyoma
35%
Medicine and Dentistry
Activin A
25%
Adenomyosis
21%
Adrenal Cell
15%
Adverse Event
17%
Androgen
16%
Aromatase
16%
Atosiban
19%
Breast Cancer
24%
Cancer Incidence
20%
Catheter Ablation
19%
Cesarean Section
18%
Diethylstilbestrol
28%
Embryo Transfer
19%
Endometrial Cancer
15%
External Cephalic Version
19%
Fertilization
19%
Fetal Heart Rate
19%
Follicle
19%
Follitropin
31%
Gestagen
21%
Gonadotropin-Releasing Hormone
28%
Granulosa Cell
26%
Human Menopausal Gonadotropin
26%
In Vitro Fertilisation
51%
Leukocyte
19%
Magnetic Resonance Imaging
29%
Malignant Neoplasm
27%
MR-guided Focused Ultrasound
36%
mRNA Vaccine
19%
Neoplasm
23%
Nuclear Magnetic Resonance
54%
Ovarian Cancer
17%
Ovarian Hyperstimulation Syndrome
43%
Ovulation
21%
Ovulation Induction
18%
Polycystic Ovary Syndrome
29%
Pregnancy Rate
14%
Premature Labor
19%
Progesterone
16%
Prospective Study
16%
Quality of Life
18%
Standardized Incidence Ratio
16%
Steroid 17alpha Monooxygenase
19%
Surgery
16%
Symptom
42%
Tocolysis
19%
Ultrasound Surgery
75%
Uterine Fibroid
100%
Uterine Myomectomy
16%
Vaginal Delivery
14%